The COBRE Center for Studies of Host Response to Cancer Therapy receives guidance from an Internal Advisory Committee that consists of highly successful investigators and UAMS administrators from different Colleges and Institutes at UAMS. The Internal Advisory Committee assists the Center in overcoming administrative hurdles, locating helpful facilities and resources on campus, among others. The External Advisory Committee consists of four members who are not otherwise associated with UAMS and have a research or clinical expertise in host response to cancer therapy and/or in the administration of COBRE Centers. The main role of the External Advisory Committee is to assist the Center in determining scientific progress.
Internal Advisory Committee
The Center for Studies of Host Response to Cancer Therapy Internal Advisory Committee consists of:
- Shuk-Mei Ho, Ph.D.
UAMS Vice Chancellor for Research
- Paula Roberson, Ph.D.
Chair, UAMS Department of Biostatistics
- Cindy Stowe, Pharm.D.
Dean, UAMS College of Pharmacy
- Fen Xia, M.D., Ph.D.
Chair, UAMS Department of Radiation Oncology
External Advisory Committee
The Center for Studies of Host Response to Cancer Therapy External Advisory Committee consists of:
- Mark Evers, M.D.
Director, Markey Cancer Center, University of Kentucky
- Hartmut Jaeschke, Ph.D.
Chair, Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center
- Daniel Mulrooney, M.D.
Faculty, Cancer Survivorship Division, St. Jude Children’s Research Hospital
- Douglas Spitz, Ph.D.
Director, Free Radical and Radiation Biology Program, University of Iowa